Differential mRNA expression of prostaglandin receptor subtypes in macrophage activation

Neil Hubbard, S. H. Lee, D. Lim, Kent L Erickson

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Assessing the regulation of macrophage receptors for prostaglandin (PGE2) is essential to understanding the control which that potent lipid mediator has in modulating macrophage activities. The purpose of this study was to assess the differential mRNA expression of PGE2 receptor subtypes (EP) during macrophage exposure to activating and transducing agents. RAW 264.7 macrophages constitutively expressed mRNA for EP2, EP3 and EP4 receptor subtypes. Messenger RNA for EP4 was expressed at a much higher level when compared to EP2 in unstimulated macrophages as assessed by kinetic quantitative RT-PCR. When macrophages were stimulated with LPS, EP2 mRNA levels were 12-fold higher when compared to unstimulated macrophages, while EP4 mRNA remained unchanged. Conversely, mRNA levels of both EP2 and EP4 receptors were lower after macrophages were treated with IFN-γ. Messenger RNA levels of both receptors were lower in macrophages after treatment with PGE2 or dibutyryl (db) cAMP. Addition of the PKA inhibitor H89 reversed the effects of PGE2 and dbcAMP to varying degrees. Proteosome and p38 MAP kinase inhibitors blocked the LPS-stimulated increase in EP2 mRNA levels. Those inhibitors had no effect on EP4 mRNA. Thus, activating agents such as LPS and IFN-γ may differentially regulate mRNA for PGE2 receptor types in macrophages but the ligand and its associated signal transducing factors probably have similar regulatory effects.

Original languageEnglish (US)
Pages (from-to)287-294
Number of pages8
JournalProstaglandins Leukotrienes and Essential Fatty Acids
Volume65
Issue number5-6
DOIs
StatePublished - 2001

Fingerprint

Prostaglandin Receptors
Macrophage Activation
Macrophages
Chemical activation
Messenger RNA
Prostaglandin E Receptors
Dinoprostone
p38 Mitogen-Activated Protein Kinases

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Differential mRNA expression of prostaglandin receptor subtypes in macrophage activation. / Hubbard, Neil; Lee, S. H.; Lim, D.; Erickson, Kent L.

In: Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 65, No. 5-6, 2001, p. 287-294.

Research output: Contribution to journalArticle

@article{01feec3df3054c5e9a6830642df8826a,
title = "Differential mRNA expression of prostaglandin receptor subtypes in macrophage activation",
abstract = "Assessing the regulation of macrophage receptors for prostaglandin (PGE2) is essential to understanding the control which that potent lipid mediator has in modulating macrophage activities. The purpose of this study was to assess the differential mRNA expression of PGE2 receptor subtypes (EP) during macrophage exposure to activating and transducing agents. RAW 264.7 macrophages constitutively expressed mRNA for EP2, EP3 and EP4 receptor subtypes. Messenger RNA for EP4 was expressed at a much higher level when compared to EP2 in unstimulated macrophages as assessed by kinetic quantitative RT-PCR. When macrophages were stimulated with LPS, EP2 mRNA levels were 12-fold higher when compared to unstimulated macrophages, while EP4 mRNA remained unchanged. Conversely, mRNA levels of both EP2 and EP4 receptors were lower after macrophages were treated with IFN-γ. Messenger RNA levels of both receptors were lower in macrophages after treatment with PGE2 or dibutyryl (db) cAMP. Addition of the PKA inhibitor H89 reversed the effects of PGE2 and dbcAMP to varying degrees. Proteosome and p38 MAP kinase inhibitors blocked the LPS-stimulated increase in EP2 mRNA levels. Those inhibitors had no effect on EP4 mRNA. Thus, activating agents such as LPS and IFN-γ may differentially regulate mRNA for PGE2 receptor types in macrophages but the ligand and its associated signal transducing factors probably have similar regulatory effects.",
author = "Neil Hubbard and Lee, {S. H.} and D. Lim and Erickson, {Kent L}",
year = "2001",
doi = "10.1054/plef.2001.0327",
language = "English (US)",
volume = "65",
pages = "287--294",
journal = "Prostaglandins Leukotrienes and Essential Fatty Acids",
issn = "0952-3278",
publisher = "Churchill Livingstone",
number = "5-6",

}

TY - JOUR

T1 - Differential mRNA expression of prostaglandin receptor subtypes in macrophage activation

AU - Hubbard, Neil

AU - Lee, S. H.

AU - Lim, D.

AU - Erickson, Kent L

PY - 2001

Y1 - 2001

N2 - Assessing the regulation of macrophage receptors for prostaglandin (PGE2) is essential to understanding the control which that potent lipid mediator has in modulating macrophage activities. The purpose of this study was to assess the differential mRNA expression of PGE2 receptor subtypes (EP) during macrophage exposure to activating and transducing agents. RAW 264.7 macrophages constitutively expressed mRNA for EP2, EP3 and EP4 receptor subtypes. Messenger RNA for EP4 was expressed at a much higher level when compared to EP2 in unstimulated macrophages as assessed by kinetic quantitative RT-PCR. When macrophages were stimulated with LPS, EP2 mRNA levels were 12-fold higher when compared to unstimulated macrophages, while EP4 mRNA remained unchanged. Conversely, mRNA levels of both EP2 and EP4 receptors were lower after macrophages were treated with IFN-γ. Messenger RNA levels of both receptors were lower in macrophages after treatment with PGE2 or dibutyryl (db) cAMP. Addition of the PKA inhibitor H89 reversed the effects of PGE2 and dbcAMP to varying degrees. Proteosome and p38 MAP kinase inhibitors blocked the LPS-stimulated increase in EP2 mRNA levels. Those inhibitors had no effect on EP4 mRNA. Thus, activating agents such as LPS and IFN-γ may differentially regulate mRNA for PGE2 receptor types in macrophages but the ligand and its associated signal transducing factors probably have similar regulatory effects.

AB - Assessing the regulation of macrophage receptors for prostaglandin (PGE2) is essential to understanding the control which that potent lipid mediator has in modulating macrophage activities. The purpose of this study was to assess the differential mRNA expression of PGE2 receptor subtypes (EP) during macrophage exposure to activating and transducing agents. RAW 264.7 macrophages constitutively expressed mRNA for EP2, EP3 and EP4 receptor subtypes. Messenger RNA for EP4 was expressed at a much higher level when compared to EP2 in unstimulated macrophages as assessed by kinetic quantitative RT-PCR. When macrophages were stimulated with LPS, EP2 mRNA levels were 12-fold higher when compared to unstimulated macrophages, while EP4 mRNA remained unchanged. Conversely, mRNA levels of both EP2 and EP4 receptors were lower after macrophages were treated with IFN-γ. Messenger RNA levels of both receptors were lower in macrophages after treatment with PGE2 or dibutyryl (db) cAMP. Addition of the PKA inhibitor H89 reversed the effects of PGE2 and dbcAMP to varying degrees. Proteosome and p38 MAP kinase inhibitors blocked the LPS-stimulated increase in EP2 mRNA levels. Those inhibitors had no effect on EP4 mRNA. Thus, activating agents such as LPS and IFN-γ may differentially regulate mRNA for PGE2 receptor types in macrophages but the ligand and its associated signal transducing factors probably have similar regulatory effects.

UR - http://www.scopus.com/inward/record.url?scp=0035724880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035724880&partnerID=8YFLogxK

U2 - 10.1054/plef.2001.0327

DO - 10.1054/plef.2001.0327

M3 - Article

C2 - 11993722

AN - SCOPUS:0035724880

VL - 65

SP - 287

EP - 294

JO - Prostaglandins Leukotrienes and Essential Fatty Acids

JF - Prostaglandins Leukotrienes and Essential Fatty Acids

SN - 0952-3278

IS - 5-6

ER -